Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">ID</td><td class="align_center">Description</td><td class="align_center">GeneRatio</td><td class="align_center"><svg height="9.39034pt" id="M27" style="vertical-align:-3.42943pt" version="1.1" viewbox="-0.0498162 -5.96091 6.50656 9.39034" width="6.50656pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M474 429L457 433C435 440 389 448 367 448C348 448 323 446 309 443C266 434 195 406 148 366C78 307 23 210 23 101C23 35 55 -12 92 -12C118 -12 146 1 196 35C247 70 311 130 346 173H348L281 -148C268 -211 256 -221 208 -229L191 -232L187 -257L433 -245L437 -219L411 -216C357 -210 350 -205 362 -140L427 207C447 315 461 381 474 429ZM387 387C379 337 363 262 355 236C318 180 201 57 142 57C126 57 112 81 112 128C112 205 150 321 220 376C244 395 280 403 312 403C345 403 370 396 387 387Z"></path></g></svg> value</td><td class="align_center">Count</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">hsa04668</td><td class="align_center">TNF signaling pathway</td><td class="align_center">24/81</td><td class="align_center">4.73<span class="nowrap"><svg height="6.1673pt" id="M28" style="vertical-align:-0.2063904pt" version="1.1" viewbox="-0.0498162 -5.96091 5.50181 6.1673" width="5.50181pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M391 364C391 409 353 448 295 448C249 448 198 426 152 393C65 331 23 225 23 139C23 14 96 -12 146 -12C198 -12 280 9 367 101L351 124C300 78 242 48 194 48C129 48 109 107 109 162V191C208 213 391 266 391 364ZM313 350C313 305 268 261 113 223C132 334 187 381 217 398C227 404 244 405 261 405C290 405 313 385 313 350Z"></path></g></svg>-</span>25</td><td class="align_center">24</td></tr><tr><td class="align_left">hsa05161</td><td class="align_center">Hepatitis B</td><td class="align_center">26/81</td><td class="align_center">6.24<span class="nowrap"><svg height="6.1673pt" id="M29" style="vertical-align:-0.2063904pt" version="1.1" viewbox="-0.0498162 -5.96091 5.50181 6.1673" width="5.50181pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M391 364C391 409 353 448 295 448C249 448 198 426 152 393C65 331 23 225 23 139C23 14 96 -12 146 -12C198 -12 280 9 367 101L351 124C300 78 242 48 194 48C129 48 109 107 109 162V191C208 213 391 266 391 364ZM313 350C313 305 268 261 113 223C132 334 187 381 217 398C227 404 244 405 261 405C290 405 313 385 313 350Z"></path></g></svg>-</span>24</td><td class="align_center">26</td></tr><tr><td class="align_left">hsa04657</td><td class="align_center">IL-17 signaling pathway</td><td class="align_center">21/81</td><td class="align_center">1.83<span class="nowrap"><svg height="6.1673pt" id="M30" style="vertical-align:-0.2063904pt" version="1.1" viewbox="-0.0498162 -5.96091 5.50181 6.1673" width="5.50181pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M391 364C391 409 353 448 295 448C249 448 198 426 152 393C65 331 23 225 23 139C23 14 96 -12 146 -12C198 -12 280 9 367 101L351 124C300 78 242 48 194 48C129 48 109 107 109 162V191C208 213 391 266 391 364ZM313 350C313 305 268 261 113 223C132 334 187 381 217 398C227 404 244 405 261 405C290 405 313 385 313 350Z"></path></g></svg>-</span>22</td><td class="align_center">21</td></tr><tr><td class="align_left">hsa05167</td><td class="align_center">Kaposi sarcoma-associated herpesvirus infection</td><td class="align_center">26/81</td><td class="align_center">3.93<span class="nowrap"><svg height="6.1673pt" id="M31" style="vertical-align:-0.2063904pt" version="1.1" viewbox="-0.0498162 -5.96091 5.50181 6.1673" width="5.50181pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M391 364C391 409 353 448 295 448C249 448 198 426 152 393C65 331 23 225 23 139C23 14 96 -12 146 -12C198 -12 280 9 367 101L351 124C300 78 242 48 194 48C129 48 109 107 109 162V191C208 213 391 266 391 364ZM313 350C313 305 268 261 113 223C132 334 187 381 217 398C227 404 244 405 261 405C290 405 313 385 313 350Z"></path></g></svg>-</span>22</td><td class="align_center">26</td></tr><tr><td class="align_left">hsa05163</td><td class="align_center">Human cytomegalovirus infection</td><td class="align_center">25/81</td><td class="align_center">3.15<span class="nowrap"><svg height="6.1673pt" id="M32" style="vertical-align:-0.2063904pt" version="1.1" viewbox="-0.0498162 -5.96091 5.50181 6.1673" width="5.50181pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M391 364C391 409 353 448 295 448C249 448 198 426 152 393C65 331 23 225 23 139C23 14 96 -12 146 -12C198 -12 280 9 367 101L351 124C300 78 242 48 194 48C129 48 109 107 109 162V191C208 213 391 266 391 364ZM313 350C313 305 268 261 113 223C132 334 187 381 217 398C227 404 244 405 261 405C290 405 313 385 313 350Z"></path></g></svg>-</span>19</td><td class="align_center">25</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Relevant pathways enriched by target genes.</div>

BioMed Research International

tab2

Table 2

Table 2: Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology 

Table 2 | Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology 